User profiles for "author:Eugenio Mercuri"

Eugenio Mercuri

Catholic University
Verified email at unicatt.it
Cited by 47223

[HTML][HTML] Duchenne muscular dystrophy

D Duan, N Goemans, S Takeda, E Mercuri… - Nature Reviews …, 2021 - nature.com
Duchenne muscular dystrophy is a severe, progressive, muscle-wasting disease that leads
to difficulties with movement and, eventually, to the need for assisted ventilation and …

[HTML][HTML] Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care

E Mercuri, RS Finkel, F Muntoni, B Wirth, J Montes… - Neuromuscular …, 2018 - Elsevier
Spinal muscular atrophy (SMA) is a severe neuromuscular disorder due to a defect in the
survival motor neuron 1 (SMN1) gene. Its incidence is approximately 1 in 11,000 live births …

[HTML][HTML] Spinal muscular atrophy

A D'Amico, E Mercuri, FD Tiziano, E Bertini - Orphanet journal of rare …, 2011 - Springer
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease
characterized by degeneration of alpha motor neurons in the spinal cord, resulting in …

[HTML][HTML] Nusinersen versus sham control in infantile-onset spinal muscular atrophy

RS Finkel, E Mercuri, BT Darras… - … England Journal of …, 2017 - Mass Medical Soc
Background Spinal muscular atrophy is an autosomal recessive neuromuscular disorder
that is caused by an insufficient level of survival motor neuron (SMN) protein. Nusinersen is …

[HTML][HTML] Nusinersen versus sham control in later-onset spinal muscular atrophy

E Mercuri, BT Darras, CA Chiriboga… - … England Journal of …, 2018 - Mass Medical Soc
Background Nusinersen is an antisense oligonucleotide drug that modulates pre–
messenger RNA splicing of the survival motor neuron 2 (SMN2) gene. It has been …

Origin and timing of brain lesions in term infants with neonatal encephalopathy

F Cowan, M Rutherford, F Groenendaal, P Eken… - The Lancet, 2003 - thelancet.com
Background The role of intrapartum asphyxia in neonatal encephalopathy and seizures in
term infants is not clear, and antenatal factors are being implicated in the causal pathway for …

[PDF][PDF] Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal …

M Brockington, DJ Blake, P Prandini, SC Brown… - The American Journal of …, 2001 - cell.com
The congenital muscular dystrophies (CMD) are a heterogeneous group of autosomal
recessive disorders presenting in infancy with muscle weakness, contractures, and …

[BOOK][B] The neurological assessment of the preterm and full-term newborn infant

LMS Dubowitz, V Dubowitz, E Mercuri - 1999 - books.google.com
Clinics in Developmental Medicine No. 148 This is the second edition of the manual
describing a popular and practical tool for the clinical neurological examination of the …

[HTML][HTML] Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ …

RS Finkel, E Mercuri, OH Meyer, AK Simonds… - Neuromuscular …, 2018 - Elsevier
This is the second half of a two-part document updating the standard of care
recommendations for spinal muscular atrophy published in 2007. This part includes updated …

Spinal muscular atrophy

E Mercuri, CJ Sumner, F Muntoni, BT Darras… - Nature Reviews …, 2022 - nature.com
Spinal muscular atrophy (SMA) is a neurodegenerative disorder caused by mutations in
SMN1 (encoding survival motor neuron protein (SMN)). Reduced expression of SMN leads …